Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
Date:12/12/2011

ion at www.NUEDEXTA.com.

About PBAPatients suffering from existing neurological disease or brain injury may also suffer the added burden of pseudobulbar affect, or PBA. PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the patient's underlying emotional state. PBA outbursts result from a "short circuit" in the brain caused by another neurologic condition--such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), stroke, or traumatic brain injury. PBA can have a debilitating impact on the lives of patients, caregivers and loved ones. For more information about PBA, please visit www.PBAinfo.org.

About Avanir Pharmaceuticals, Inc.Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

Avanir® and NUEDEXTA® are registered trademarks owned by Avanir Pharmaceuticals, Inc.

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Forward Looking StatementsExcept for the historical information contained herein, the matters set forth in this press release, including statements regarding Avanir's plans, potential opportunities, financial or other expectations, projections, goals objectives, milestones, strategies, market growth, timelines, legal matters, product pipeline, clinical studies, product development and the potential benefits
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
2. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
3. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
4. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
6. Avanir Pharmaceuticals to Participate in Two Investor Conferences
7. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
8. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
9. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
10. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
11. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
(Date:7/29/2014)... RIDGE, Colo. , July 29, 2014 /PRNewswire/ ... company focused on developing a proprietary electromagnetic induction ... it entered into an agreement under which TBC ... Continuation Investments Limited (COT) in an all-stock transaction. ... Company will initially trade on the Australian Stock ...
(Date:7/29/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or ... in China , today announced that ... results on Tuesday, August 5, 2014 after the market ... a conference call at 8:00 a.m. ET on Wednesday, ... on August 6, 2014, to discuss second quarter 2014 ...
Breaking Medicine Technology:A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3
... March 29, 2011 Royal DSM, the global ... the Ambassador of the Kingdom of the Netherlands to ... North Carolina facilities on March 28, 2011. Ambassador Jones-Bos ... and Dyneema-Ultra-High Molecular Weight Polyethylene fiber operations, and toured ...
... 2011 Diopsys, Inc. has launched the new Diopsys® ... ophthalmologists detect optic nerve disease, including glaucoma and other ... leading cause of blindness in the world, reports the ... is often called the "sneak thief of sight" because ...
Cached Medicine Technology:Dutch Ambassador Visits DSM in North Carolina 2Dutch Ambassador Visits DSM in North Carolina 3New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma 2
(Date:7/29/2014)... HealthDay Reporter , MONDAY, July 28, 2014 ... disease may be able to take hormone replacement therapy soon ... according to a new study. Previous studies, including the ... harmful effects on the heart. But, many of those women ... further past menopause. In this new study, researchers ...
(Date:7/29/2014)... Beverly Hills, CA (PRWEB) July 29, 2014 ... the world’s largest uterine fibroid was recently removed from a ... 3 hours. The woman, identified only as Latha, reportedly had ... inside her. She had been experiencing fatigue and breathlessness for ... The doctors at Kumaran Hospital in Chennai only discovered the ...
(Date:7/29/2014)... AR (PRWEB) July 29, 2014 On ... a resolution declaring the week of October 12-18, 2014, ... of case management in improving healthcare outcomes for patients. ... and Senator John Boozman (R-AR), with support by the ... Management Association to honor case management professionals for their ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The ... named a 2014 ASAE Power of A ... public awareness campaign to encourage everyone age six months ... , ASAE recognized NFID for its power to enrich ... and action among consumers and professionals about the importance ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Award-winning inventor Michael ... a flatulence neutralizer specifically designed to absorb embarrassing odors in ... that can easily be stored in a desk drawer. This ... the PoofPad, users will simply sit on the pad and ... at the office and then BAM, someone appears out of ...
Breaking Medicine News(10 mins):Health News:Early Hormone Therapy May Be Safe for Women's Hearts 2Health News:Early Hormone Therapy May Be Safe for Women's Hearts 3Health News:World’s Largest Uterine Fibroid Removed from Patient 2Health News:World’s Largest Uterine Fibroid Removed from Patient 3Health News:CMSA Supports National Case Management Week Resolution Introduced in US Senate 2Health News:National Foundation for Infectious Diseases Receives Top ASAE Honors for Keeping the Nation Flu-Focused 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 3
... issue of the Journal of Clinical Sleep Medicine ... developing obstructive sleep apnea (OSA) in adolescents but not in ... of OSA among Caucasian adolescents 12 years of age and ... mass index (BMI) z-score, while the risk of OSA did ...
... Medical Center researchers have provided the most extensive account ... patients with an extremely rare premature aging syndrome. ... of the Journal of Clinical Endocrinology and Metabolism, ... should not be lumped together with those diagnosed with ...
... , , OAK BROOK, Ill., Dec. 15 ... larger role than ever. Now the University HealthSystem Consortium (UHC) ... Achieving Cost Efficiencies in Health Care, to assist value ... with the input of value analysis staff in the field, ...
... ... help people slim down, reduce facial wrinkling, and plump lips all in one minimally ... ... fat from the abdomen and inject it into the face and lips to help ...
... , ABBOTT PARK, Ill. and HOLLYWOOD, ... ) announced today a definitive agreement to acquire STARLIMS ... of laboratory information management systems, for approximately $123 million ... position in the global diagnostics market, providing advanced web-based ...
... LOVELAND, Colo., Dec. 14 Heska Corporation (Nasdaq: ... leading provider of veterinary diagnostic and specialty products, ... Company,s new DRI-CHEM® 7000 Veterinary Chemistry Analyzer (the ... Customers receiving these analyzers have invested in the ...
Cached Medicine News:Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: When high buckle is required. Overall length: 14.0 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
...
...
Medicine Products: